3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Thyroid Nodule
2
Breast Neoplasms
2
Thyroid Neoplasms
1
Recurrence
1
Pancreatic Neuroendocrine Tumors, WHO Grade I-II
1
Neuroma
1
Neuralgia
1
Lymphoma, Follicular
1
Liver Metastasis Colon Cancer
1
Lipoma
1
Klatskin Tumor
1
Kidney Neoplasms
1
Hypesthesia
1
Esophageal Neoplasms
1
Cicatrix
1
Carcinoma, Hepatocellular
1
Bone Cancer Metastatic
1
Bile Duct Neoplasms
1
Agnosia
1
Adrenocortical Adenoma
1
Adenoma, Islet Cell
1
Interventions
Specimen Handling
3
Magnetic Resonance Spectroscopy
3
Everolimus
3
lutetium Lu 177 dotatate
2
Temozolomide
2
Sunitinib
2
sargramostim
1
montanide ISA 51
1
lanreotide
1
incomplete Freund's adjuvant
1
fludarabine phosphate
1
belzutifan
1
Sorafenib
1
Radiofrequency Ablation
1
Octreotide
1
Interleukin-13
1
Histocompatibility Testing
1
Gefitinib
1
Fulvestrant
1
Fluorodeoxyglucose F18
1
Cytoreduction Surgical Procedures
1
Cyclophosphamide
1
Colony-Stimulating Factors
1
Capecitabine
1
Blood Specimen Collection
1
Biopsy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Adenoma, Islet Cell
×
Radiofrequency Ablation
×
Clear all
NCT04520932
2025-05-25
RFANET
Institut Paoli-Calmettes
Phase NA
Recruiting
82 enrolled